Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11007142 Oral cholestyramine formulation and use thereof

Patent 11007142 was granted and assigned to Albireo AB on May, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jessica Elversson0

Nils Ove Gustafsson0

Nils-Olof Lindberg0

Per-Göran Gillberg0

Date of Patent

May 18, 2021

0

Patent Application Number

161000480

Date Filed

August 9, 2018

0

Patent Citations

US Patent 10610543 Cholestyramine pellets and methods for preparation thereof

US Patent 10786529 Oral cholestyramine formulation and use thereof

US Patent 10093697 IBAT inhibitors for the treatment of liver diseases

US Patent 10487111 IBAT inhibitors for the treatment of liver diseases

US Patent 10709755 Solid formulation and method for preventing or reducing coloration thereof

Patent Citations Received

US Patent 11549878 In vitro method for determining the adsorbing capacity of an insoluble adsorbant

Patent Primary Examiner

Lakshmi S Channavajjala

0

Patent abstract

The invention relates to an oral formulation for targeted delivery of cholestyramine to the colon, comprising a plurality of cholestyramine pellets that are coated with a colon release coating. The invention also relates to the use of this formulation in the treatment of bile acid malabsorption.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11007142 Oral cholestyramine formulation and use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool